Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines

Biological Chemistry

Volumn 389, Issue 11, 2008, Pages 1441-1445

  Weirich, Gregor ^a   Mengele, Karin ^b   Yfanti, Christina ^b   Gkazepis, Apostolos ^b   Hellmann, Daniela ^b   Welk, Anita ^b   Giersig, Cecylia ^c   Kuo, Wen Liang ^d   Rosner, Marsha Rich ^d   Tang, Wei Jen ^d   Schmitt, Manfred ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Federal Institute for Drugs and Medical Devices   (Germany)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Antibody; Immunohistochemistry; Insulinase; Inverzincin; Normal tissue; Tumor cell line

Indexed keywords

INSULINASE; METALLOPROTEINASE;

ARTICLE; BONE MARROW; BREAST; CELL STRAIN HL 60; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME LOCALIZATION; GRANULOCYTE; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; LUNG; LYMPHOCYTE; PANCREAS; PERIPHERAL NERVOUS SYSTEM; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAJI CELL; SKELETAL MUSCLE; SPLEEN; THYMUS; TISSUE MICROARRAY; TROPHOBLAST; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INSULYSIN; ORGAN SPECIFICITY;

EID: 56549083191     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.157     Document Type: Article

References (31)

1. Adames, N., Blundell, K., Ashby, M.N., and Boone, C. (1995). Role of yeast insulin-degrading enzyme homologs in propheromone processing and bud site selection. Science 270, 46446-46447.
2. Authier, F., Bergeron, J.J., Ou, W.J., Rachubinski, R.A., Posner, B.I., and Walton, P.A. (1995). Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase. Proc. Natl. Acad. Sci. USA 92, 3859-3863.
3. Authier, F., Cameron, P.H., and Taupin, V. (1996). Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells. Biochem. J. 319, 149-158.
4. Barrett, A.J. and Rawlings, N.D. (2004). Introduction: metallopeptidases and their clans. In: Handbook of Proteolytic Enzymes, A.J. Barrett, N.D. Rawlings and J.F. Woessner, eds. (London, UK: Elsevier Academic Press), pp. 231-268.
5. Becker, A.B. and Roth, R.A. (1995). Insulysin and pitrilysin: insulin-degrading enzymes of mammals and bacteria. Methods Enzymol. 248, 693-703.
6. Bennett, R.G., Fawcett, J., Kruer, M.C., Duckworth, W.C., and Hamel, F.G. (2003). Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme. J. Endocrinol. 177, 399-405.
7. Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., Yhu, S., McInnis, MG., Go, R.C., Vekrellis, K., et al. (2000). Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290, 2302-2303.
8. Camberos, M.C., Pérez, A.A., Udrisar, D.P., Wanderley, M.I., and Cresto, J.C. (2001). ATP inhibits insulin-degrading enzyme activity. Exp. Biol. Med. 226, 334-341.
9. Castro, A., Ziegels-Weissman, J., Buschbaum, P., Voigt, W., Morales, A., and Nadji, M. (1980). Immunochemical demonstration of immunoreactive insulin in human breast cancer. Res. Commun. Chem. Pathol. Pharmacol. 29, 171-182.
10. Chang, L.L. Stout, L.E., Wong, W.D., Buls, J.G., Rothenberger, D.A., Shier, W.T., Sorenson, R.L., and Bai, J.P. (1997). Immunohistochemical localization of insulin-degrading enzyme along the rat intestine, in the human colon adenocarcinoma cell line (Caco-2), and in human ileum. J. Pharm. Sci. 86, 116-119.
11. Chesneau, V. and Rosner, M.R. (2000). Functional human insulin-degrading enzyme can be expressed in bacteria. Protein Expr. Purif. 19, 91-98.
12. Duckworth, W.C., Bennett, R.G., and Hamel, F.G. (1998). Insulin degradation: progress and potential. Endocr. Rev. 19, 608-624.
13. Farris, W., Leissring, M.A., Hemming, M.L., Chang, A.Y., and Selkoe, D.J. (2005). Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid β-protein. Biochemistry 44, 6513-6525.
14. Fawcett, J., Permana, P.A., Levy, J.L., and Duckworth, W.C. (2007). Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing. Arch. Biochem. Biophys. 468, 128-133.
15. Gehm, B.D. and Rosner, M.R. (1991). Regulation of insulin, epidermal growth factor, and transforming growth factor-α levels by growth factor-degrading enzymes. Endocrinology 128, 1603-1610.
16. Hamel, F.G., Mahoney, M.J., and Duckworth, W.C. (1991). Degradation of intraendosomal insulin by insulin degrading enzyme without acidification. Diabetes 40, 436-443.
17. Harada, S., Smith, R.M., Smith, J.A., and Jarett, L. (1993). Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells - evidence of a cytosolic pathway. Endocrinology 132, 2293-2298.
18. Hersh, L.B. (2006). The insulysin (insulin degrading enzyme) enigma. Cell. Mol. Life Sci. 63, 2432-2434.
19. Kuo, W.L., Montag, A.G., and Rosner, M.R. (1993). Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. Endocrinology 132, 604-611.
20. Leissring, M.A., Farris, W., Wu, X., Christodoulou, D.C., Haigis, M.C., Guarente, L., and Selkoe, D.J. (2004). Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria. Biochem. J. 383, 439-446.
21. Melino, G., Draoui, M., Bernardini, S., Bellincampi, L., Reichert, U., and Cohen, P. (1996). Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines. Cell Growth Differ. 7, 787-796.
22. Neal, G.W. and Kitabchi, A.E. (1982). Insulin degradation by human skeletal muscle. Biochim. Biophys. Acta 719, 259-266.
23. Qiu W.Q. and Folstein, M.F. (2006). Insulin, insulin-degrading enzyme and amyloid-b peptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging 27, 190-198.
24. Radulescu, R.T., Hufnagel, C., Luppa, P., Hellebrand, H., Kuo, W.L., Rosner, M.R., Harbeck, N., Giersig, C., Meindl, A., Schmitt, M., and Weirich, G. (2007). Immunohistochemical demonstration of the zinc metalloprotease insulin-degrading enzyme in normal and malignant human breast: correlation with tissue insulin levels. Int. J. Oncol. 30, 73-80.
25. Shen, Y., Joachimiak, A., Rosner, M.R., and Tang, W.J. (2006). Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443, 870-874.
26. Shii, K., Yokono, K., Baba, S., and Roth, R.A. (1986). Purification and characterization of insulin-degrading enzyme from human erythrocytes. Diabetes 35, 675-683.
27. Simon, R., Mirlacher, M., and Sauter, G. (2003). Tissue microarrays in cancer diagnosis. Expert Rev. Mol. Diagn. 3, 421-430.
28. Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885.
29. Spring-Mills, E.J., Stearns, S.B., Numann, P.J., and Smith, P.H. (1984). Immunocytochemical localization of insulin- and somatostatin-like material in human breast tumors. Life Sci. 35, 185-190.
30. Su, A.I., Wiltshire, T., Batalov, S., Lapp, H., Ching, KA., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, et al. (2004). A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101, 6062-6067.
31. Valera Mora, M.E., Scarfone, A., Calvani, M., Greco, A.V., and Mingrone, G. (2003). Insulin clearance in obesity. J. Am. Coll. Nutr. 22, 487-493.